Medtronic plc (NYSE:MDT) is reporting first quarter financial results on Tuesday 25th August 2020, before market open.
According to analysts surveyed by Thomson Reuters, MDT is expected to report 1Q21 income of $ 0.18 per share from revenue of $ 5439.62 million.
For the full year, analysts anticipate top line of $ 28006.10 million, while looking forward to income of $ 3.71 per share bottom line.
Previous Quarter Performance
Medtronic plc outlined income for the fourth quarter of $ 0.58 per share, from the revenue of $ 5,998.00 million. The quarterly earnings decreased 62.34 percent while revenues reduced 26.37 percent compared with the same quarter last year.
Street analysts expected Medtronic plc to report income of $ 1.06 per share on revenue of $ 7016.61 million for the fourth quarter. The bottom line results missed street analysts by $ 0.48 or 45.28 percent, at the same time, top line results fell short of analysts by $ 1 million or 14.52 percent.
Stock Performance
Shares of Medtronic plc traded high $ 1.40 or 1.42 percent on Monday, reaching $ 100.13 with volume of 5.26 million shares. Medtronic plc has traded high as $ 101.29 and has cracked $ 99.38 on the downward trend
According to the previous trading day, closing price of $ 100.13, representing a 36.88 % increase from the 52 week low of $ 72.13 and a 19.17 % decrease over the 52 week high of $ 122.15.
The company has a market capital of $ 134.50 billion and is part of the Healthcare sector and Medical Devices industry.
Recent Stock Dividend Announcement
On May 20, 2020, the board of directors authorized quarterly dividend of $ 0.58 per share to holders of record as of the close of business on June 26, 2020, with payment date of July 17, 2020 and ex-dividend date on June 25, 2020.
Conference Call
Medtronic plc will be hosting a conference call at 8:00 AM eastern time on 25th August 2020, to discuss its 1Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website edge.media-server.com/mmc/p/zoih87i6
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates in four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software.
